Nigeria’s first molecular diagnostics firm, Stack Diagnostics has launched a new product called DiagnoseMe Africa.
DiagnoseMe Africa is an online platform will contribute to the Nigerian health sector by providing access to over 300 life-saving tests not easily accessible in the country.
According to the company’s CEO, Dr Abasi Ene-Obong, “There are a lot of life-threatening diseases that can be prevented, managed and cured but in Nigeria, we don’t have the tools required for early detection.
“About 100 thousand women in Nigeria have breast cancer yearly and of those, around 80 thousand die. Prostate cancer which kills a lot of men in Nigeria has stopped being a killer in many other countries…DiagnoseMe is set on breaking the dependence on medical tourism by creating ease of access to these tests.” He said.
See Also: Paystack Raises $8m Series A Funding from Stripe, Visa, Tencent And Other Angel Investors
DiagnoseMe presents a platform for anyone to carry out the most innovative medical diagnostic tests using the latest genetic technology. Asides cancers, people can also test for food allergies, carry out non-invasive prenatal tests and paternity tests.
“DiagnoseMe is making things easier for everyone as consumers have access to doctors, doctors and consumers have access to tests and doctors have access to other doctors. It’s a web of shared knowledge to proffer the best solution.” Dr Ani, a medical adviser at Stack Diagnostics said.
More Tech Stories:
- Nigerian Airline, Arik in Data Breach Scandal
- Application Window Opens Up for Airbus’ Africa4Future Accelerator
- Ghanaian Government Currently in Search of Private Partners for Its Proposed Airline
- MFS Africa Lands Series-B Round Fund from LUN Partners Group
- Kenya, South Africa Top META Region’s ICT Growth Index
